ARTICLE | Distillery Therapeutics
Neurology
July 10, 2018 9:37 PM UTC
Cell culture and mouse studies identified a peptide-based antagonist of the OPRD1/MOR heterodimer that could help treat opiate withdrawal. Chemical synthesis and testing in cell-based competitive bind...
BCIQ Company Profiles